Status | Study |
Terminated |
Study Name: Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis Condition: Focal Segmental Glomerulosclerosis Date: 2009-08-10 Interventions: Drug: prednisone, FK506, MMF 1 |
Terminated |
Study Name: Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor Condition: Focal Segmental Glomerulosclerosis Date: 2008-12-31 Interventions: Drug: Galactose Oral galactose, 0.2 g/kg/dose twice daily for 28 days |
Withdrawn |
Study Name: Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5 Condition: Focal Segmental Glomerulosclerosis Date: 2008-12-31 Interventions: Drug: Galactose Oral galactose, 0.2 g/kg/dose twice daily for 28 days |
Completed |
Study Name: Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Condition: Focal Segmental Glomerulosclerosis Date: 2008-12-22 Interventions: Drug: Adalimumab Adalimumab 24 |
Completed |
Study Name: Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis Condition: Proteinuria Focal Segmental Glomerulosclerosis Date: 2008-12-02 Interventions: Drug: tripterygium wilfordii (TW) Pre 30mg/d +TW 120 mg/d, po for 12 weeks |
Terminated |
Study Name: Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS) Condition: Focal Segmental Glomerulosclerosis Date: 2008-10-27 Interventions: Drug: FG-3019 FG-3019 5 mg/kg IV given over 2 hours every 2 weeks for 8 weeks |
Completed |
Study Name: Rituximab Treatment of Focal Segmental Glomerulosclerosis Condition: Focal Segmental Glomerulosclerosis (FSGS) Date: 2007-10-26 Interventions: Drug: rituximab 375 mg/m2 intravenously for 4 doses |
Completed |
Study Name: Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS Condition: Focal Segmental Glomerulosclerosis Date: 2007-04-20 Interventions: Biological: GC1008 1 mg/kg, IV |
Withdrawn |
Study Name: Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis Condition: Focal Glomerulosclerosis Date: 2006-03-13 Interventions: Drug: Tacrolimus Tacrolimus Other Name: Tacrolimus, |
Completed |
Study Name: Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS) Condition: Focal Glomerulosclerosis Date: 2005-09-10 Interventions: Drug: Rosiglitazone (Avandia) |